Stock Events

Stock Events

Organon 

$13.80
648
+$0.13+0.95%Thursday 08:45

Statistics

Day High
13.81
Day Low
13.78
52W High
13.9
52W Low
13.06
Volume
2,403
Avg. Volume
-
Mkt Cap
3.62B
P/E Ratio
-
Dividend Yield
0.58%
Dividend
0.08

Upcoming

Dividends

0.58%Dividend Yield
Sep 2026
$0.02
Jun 2026
$0.02
Mar 2026
$0.02
Dec 2025
$0.02
Sep 2025
$0.02
10Y Growth
N/A
5Y Growth
-22.16%
3Y Growth
-58.51%
1Y Growth
-86.67%

Earnings

Oct 30Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.63
0.76
0.88
1.01
Expected EPS
0.88
Actual EPS
N/A

Financials

3.01%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.22BRevenue
187MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OGN.BOATS. It's not an investment recommendation.
Merck
134
MRK
Pfizer
120
PFE
AT&T
114
T
Realty Income
112
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company that competes with Organon in the areas of women's health and biosimilars, making it a direct competitor.
Merck
MRK
Mkt Cap368.89B
Merck, the former parent company of Organon, competes in the pharmaceutical sector, including women's health and vaccine products.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Organon in the pharmaceuticals sector, particularly in women's health, with a focus on therapies and treatments.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson is a diversified healthcare giant that competes across various segments, including pharmaceuticals relevant to Organon's market.
AMGEN
AMGN
Mkt Cap251.94B
Amgen is a biopharmaceutical company that competes with Organon in the biosimilars market, offering alternative products.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk is a global healthcare company that, through its biopharmaceutical products, competes with Organon in areas like hormone replacement therapies.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.09B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Organon in the generics and women's health market.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Organon in developing and commercializing prescription pharmaceuticals.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline is a global healthcare company that competes with Organon in pharmaceuticals and vaccines, including areas of women's health.
Sanofi
SNY
Mkt Cap106.24B
Sanofi is a global biopharmaceutical company focusing on human health, competing with Organon in healthcare solutions, including women's health.

About

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Show More
CEO
ISIN
US68622V1061

Listings

STU
DE
7XP.STU
MI
IT
1OGN.MI
LSE
GB
0A9W.LSE
MU
DE
7XP.MU

0 Comments

Share your thoughts

FAQs

What is Organon stock price today?▼
The current price of OGN.BOATS is $13.80 USD — it has increased by +0.95% in the past 24 hours. Watch Organon stock price performance more closely on the chart.
What is Organon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Organon stocks are traded under the ticker OGN.BOATS.
What is Organon market cap?▼
Today Organon has the market capitalization of 3.62B
When is the next Organon earnings date?▼
Organon is going to release the next earnings report on February 18, 2027.
What is Organon revenue for the last year?▼
Organon revenue for the last year amounts to 6.22B USD.
What is Organon net income for the last year?▼
OGN.BOATS net income for the last year is 187M USD.
Does Organon pay dividends?▼
Yes, OGN.BOATS dividends are paid quarterly. The last dividend per share was 0.02 . As of today, Dividend Yield (FWD)% is 0.58%.
In which sector is Organon located?▼
Organon operates in the Other sector.
When did Organon complete a stock split?▼
Organon has not had any recent stock splits.